Evidence map›Paper›PMID 34981207›Full record

ArticleJournal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry2022

Structural characterization and antileishmanial activity of newly synthesized organo-bismuth(V) carboxylates: experimental and molecular docking studies.

Sohaila Andleeb, Imtiaz-Ud-Din, Muhammad Khawar Rauf, Syed Sikander Azam, Ihsan-Ul Haq, Muhammad Nawaz Tahir, Naila Zaman

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.7field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 7 citations in OpenAlex.

  1. Bioactive Bismuth Compounds: Is Their Toxicity a Barrier to Therapeutic Use?International journal of molecular sciences · 2024
    Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Sohaila AndleebNUTECH School of Applied Sciences and Humanities, National University of Technology, Islamabad, 44000, Pakistan. drsohailaandleeb@gmail.com.
Imtiaz-Ud-DinDepartment of Chemistry, Quaid-I-Azam University, Islamabad, 45320, Pakistan. drimtiazuddin@yahoo.com.
Muhammad Khawar RaufDepartment of Chemistry, Quaid-I-Azam University, Islamabad, 45320, Pakistan.ORCID 0000-0001-9994-4033
Syed Sikander AzamComputational Biology Lab, National Center for Bioinformatics, Quaid-I-Aam University, Islamabad, 45320, Pakistan.
Ihsan-Ul HaqDepartment of Pharmacy, Quaid-I-Azam University, Islamabad, 45320, Pakistan.
Muhammad Nawaz TahirDepartment of Physics, University of Sargodha, Sargodha, 40100, Pakistan.
Naila ZamanComputational Biology Lab, National Center for Bioinformatics, Quaid-I-Aam University, Islamabad, 45320, Pakistan.
Quaid-i-Azam University · PKNational University of Technology · PKUniversity of Sargodha · PK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In a quest to discover new formulations for the treatment of various parasitic diseases, a series of heteroleptic triorganobismuth(V) biscarboxylates of type [BiR

Indexed as

Antiprotozoal AgentsBismuthCarboxylic AcidsMolecular Docking SimulationSpectroscopy, Fourier Transform InfraredAntiprotozoal AgentsBismuthCarboxylic AcidsAntileishmanialBismuth(V)CarboxylatesTrypanothione reductaseTrypanothione synthetase-amidase

Identifiers

PMID34981207
OpenAlexW4206643338

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.